Wockhardt · NSE: WOCKPHARMA · BSE: 532300
Q3 FY24 results · Oct–Dec 2023
Wockhardt reported revenue from operations of ₹701.00 crore (up 0.3% from Q3 FY23) and net loss of ₹86.00 crore for Q3 FY24 (Oct–Dec 2023), on a consolidated basis.
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 701.00 | 699.00 | +0.3% | 753.00 | −6.9% |
| Other income | 8.00 | 2.00 | +300.0% | 24.00 | −66.7% |
| Total income | 709.00 | 701.00 | +1.1% | 777.00 | −8.8% |
| Profit before tax | (87.00) | (105.00) | Loss narrowed | (35.00) | Loss widened |
| Net profit for the period | (86.00) | (102.00) | Loss narrowed | (73.00) | Loss widened |
| Attributable to shareholders of the company | (83.00) | (96.00) | Loss narrowed | (77.00) | Loss widened |
| EPS, basic (₹) | (5.75) | (6.62) | Loss narrowed | (5.37) | Loss widened |
| Net margin (%) | -12.3 | -14.6 | -9.7 |
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 288.00 | 282.00 | +2.1% | 260.00 | +10.8% |
| Other income | 5.00 | 18.00 | −72.2% | 6.00 | −16.7% |
| Total income | 293.00 | 300.00 | −2.3% | 266.00 | +10.2% |
| Profit before tax | (74.00) | (55.00) | Loss widened | (107.00) | Loss narrowed |
| Net profit for the period | (74.00) | (55.00) | Loss widened | (107.00) | Loss narrowed |
| EPS, basic (₹) | (5.14) | (3.81) | Loss widened | (7.39) | Loss narrowed |
| Net margin (%) | -25.7 | -19.5 | -41.2 |
Consolidated
- Filed with BSE
- 14 Feb 2024, 17:18 IST
- Board meeting
- 14 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 14 Feb 2024, 17:18 IST
- Board meeting
- 14 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE